Susquehanna International Group, LLP Novo Nordisk A S Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Susquehanna International Group, LLP holds 285,708 shares of NVO stock, worth $22.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
285,708
Previous 889,702
67.89%
Holding current value
$22.6 Million
Previous $106 Million
76.8%
% of portfolio
0.0%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding NVO
# of Institutions
1,884Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.57 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.22 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.03 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$998 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$964 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $178B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...